Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. US FDA approves Novartis' kidney disease drug - AOL

    www.aol.com/news/us-fda-approves-novartis-kidney...

    August 7, 2024 at 2:23 PM. By Sriparna Roy. (Reuters) -The U.S. Food and Drug Administration has approved the use of Novartis' drug to reduce excess protein in the urine of patients with a type of ...

  3. Novartis, Viatris face new lawsuit over 'HeLa' cell misuse claims

    www.aol.com/news/novartis-viatris-face-lawsuit...

    Novartis and Viatris were hit with a federal lawsuit in Maryland on Monday by the family of a woman whose tissue cells were taken from her body in the 1950s and used to fuel medical research and ...

  4. Novartis to acquire cancer-focused MorphoSys for $2.9 billion

    www.aol.com/news/novartis-acquire-cancer-drug...

    (Reuters) -Drugmaker Novartis AG said it will acquire MorphoSys AG, a developer of cancer treatments, for 2.7 billion euros ($2.9 billion), adding a promising rare bone-marrow cancer treatment ...

  5. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. [ 4][ 5] Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to ...

  6. Vasant Narasimhan - Wikipedia

    en.wikipedia.org/wiki/Vasant_Narasimhan

    He spent 8 years working in Novartis Vaccines, at the time a non-profit division focused on developing vaccines for children and patients around the world and served as the Global Head of Development, Novartis Vaccines in the US between 2012 and 2014 before moving to Sandoz as Global Head of Biopharmaceuticals and Oncology Injectables. [6] [17]

  7. Novartis Gene Therapies - Wikipedia

    en.wikipedia.org/wiki/Novartis_Gene_Therapies

    Novartis Gene Therapies, until 2020 known as AveXis, is a biotechnology company that develops treatments for rare neurological genetic disorders. It was founded in Dallas , Texas , United States in 2012 by John Carbona after reorganizing a company called BioLife Cell Bank founded by David Genecov and John Harkey.

  8. Why Novartis Stock Is Down Today Despite Topping Q2 ... - AOL

    www.aol.com/why-novartis-stock-down-today...

    Novartis turned $12.5 billion worth of revenue into per-share earnings of $1.97 in Q2, topping expectations for a profit of $1.89 per share on sales of a little less than $12.4 billion. Better ...

  9. Novartis Foundation - Wikipedia

    en.wikipedia.org/wiki/Novartis_Foundation

    The Novartis Foundation was a scientific and educational charity, formed in 1949 by the Swiss company Ciba, now Novartis, and dissolved in 2008. It was the direct successor to the Ciba Foundation, and the changed name (Novartis Foundation) reflected the new name of Ciba, after merging with Sandoz. The Foundation was the brainchild of Robert ...